Recent Headlines
Within Biotechnology
Baxa Corporation Wins Two 2009 Colorado BMA Gold Key Awards
Baxa Corporation campaigns awarded 2009 Business Marketing Association Gold Key Awards for Product Literature and Websites/Search Engine Marketing. The BMA Gold Key Awards are one of Colorado’s most highly acclaimed marketing competitions, with entries reviewed by a panel of six independent judges from across the US. - April 27, 2009 - Baxa Corporation
Colorado BioScience Association Names Rick Jory Board Chair, Announces 2009 Sponsors and Appoints Seven New Board Members
Rick Jory, CEO of Sandhill Scientific, Inc., Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2009 annual meeting yesterday. Jory assumes chairperson responsibilities from Jack Wheeler, MicroPhage, Inc. In other action, seven new members were named to the CBSA board of directors. - April 23, 2009 - Colorado BioScience Association
LacPro Industries, LLC Named Techpoint Mira Award Finalist
Fort Wayne-based LacPro, a biotherapeutic company developing a product for Clostridium difficile Infection, has been named a finalist for Innovation of the Year. - April 22, 2009 - LacPro Industries LLC
Baxa ‘Ecological’ Program Promotes Benefits of Recycling
Commitment to ‘green’ activities at Baxa Corporation celebrates Earth Day 2009 while providing reduced costs and workplace benefits. Historically, Baxa has chosen product designs and raw materials that reduce waste and improve patient safety and minimize environmental impact. More recently, the company has introduced specific initiatives for reducing its environmental impact and advancing its environmental stewardship. - April 20, 2009 - Baxa Corporation
MicroTransponder CEO Will Rosellini to Testify Before the U.S. House of Representatives Concerning Neurotechnology
CEO Will Rosellini will testify before the U.S. House of Representatives regarding the Federal SBIR program on Wednesday, April 22. SBIR awards to MicroTransponder have funded neurotechnology research for TBI, Tinnitus, and PTSD resulting in potential new treatments for soldiers. - April 19, 2009 - MicroTransponder Inc.
Quintiles Named to Top 25 Canadian Employers List
Quintiles has been recognized by the Great Place to Work® (GPTW) Institute Canada as one of the top 25 companies to work for in the country. It is the first time Quintiles has made the Canadian GPTW list since the Institute’s awards were launched there in 2005. Quintiles is the... - April 17, 2009 - Quintiles
AnaSpec Introduces New HiLyte Fluor™ 594 Labeled Secondary Antibodies & Streptavidin
AnaSpec has introduced a line of secondary antibodies and streptavidin conjugated to the newest member of the HiLyte Fluor™ family - HiLyte Fluor™ 594 (Ex/Em=593/616 nm). Using optimal fluorophore/protein labeling ratio, these HiLyte Fluor™ 594-IgG conjugates exhibit high... - April 15, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte Luminescent Peroxidase Assay Kits
AnaSpec has introduced two new luminescent read-out assay kits for determining peroxidase activity – the SensoLyte Luminescent Peroxidase Assay Kit and the SensoLyte Luminescent Peroxidase ELISA Assay Kit. - April 12, 2009 - AnaSpec, EGT Group
AnaSpec Introduces Series of Cell Penetrating Peptides (CPP)
AnaSpec has CPPs such as (Arg)9, Antennapedia, TAT and others. Offerings include green fluorescent labeled (e.g. FAM or FITC) CPP, red labeled (e.g. TAMRA), Cys conjugated CPPs or Cys(Npys) conjugated CPP. - April 08, 2009 - AnaSpec, EGT Group
Baxa Corporation Gets Social with Facebook and LinkedIn
Colorado Medical Device Company, Baxa Corporation, invites customers to just “have fun” and use social media tools to connect and share experience on Facebook and LinkedIn. More and more healthcare facilities, medical device companies and hospitals are using social media as a powerful tool to interact with their customers on a more personal level – complementing their more formal Web site content. - April 06, 2009 - Baxa Corporation
World's Leading Scientists Meet to Examine Barriers for Stem Cell Therapies to Cure Spinal Cord Injury
Following President Barack Obama's decision to lift the ban on federal funding for embryonic stem cell research, medical and scientific experts will converge at the University of Georgia to discuss how recent advances in stem cell research can be translated into cures for spinal cord injuries. The... - March 31, 2009 - Bedford Stem Cell Research Foundation
Massachusetts Scientists Make Stem Cell Discovery
Cell Multiplication Controlled by a Surprising set of Genes. Stem cell researcher Dr. Ann Kiessling has discovered that early human embryo cells express CLOCK, and other circadian genes, that other human cells growing in laboratories did not. This was a surprise. According to Professor Jose Cibelli of Michigan State University, "This is a seminal paper. I am sure we will be referring back to it 10, 20 years from now." - March 30, 2009 - Bedford Stem Cell Research Foundation
MoBiTec GmbH, Germany, is Offering Photochromic Fluorescent Protein EosFP
The Green-to-Red switchable, photochromic Fluorescent Protein „EosFP“ offers advantageous applications in Molecular Cell Biology, and is now available through the German biotech company MoBiTec GmbH. With violet light, single cells in an EosFP marked (green) cell population can be switched to red, so that their fate can be followed selectively, for example in embryonic cell differentiation. Alternatively, a particular compartment within an EosFP marked (green) cell can be switched to red. - March 25, 2009 - MoBiTec GmbH
AnaSpec’s ClearPoint™ Peptides Win Best New Product Award
AnaSpec’s ClearPoint™ Peptides were awarded the Best New Product Award in the category of Biological Samples and Reagents at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference which was held in San Francisco, CA from February 25-27. By spiking protein tryptic digests... - March 25, 2009 - AnaSpec, EGT Group
Colorado Bioscience Association Teams with Twenty-Six National & State Partners to Launch the ‘We Work for Health’ Initiative in Colorado
The Colorado BioScience Association is partnering with twenty-six national and state entities to announce the ‘We Work For Health’ initiative in Colorado. The launch event – Saving Lives, Creating Jobs -- occurs today at University of Colorado Denver, Anschutz Medical Campus in Aurora. U.S. Senator Michael Bennet is the special guest speaker. - March 20, 2009 - Colorado BioScience Association
Cerulean’s John Avellanet Interviewed on 21 CFR Part 11, Computer Validation, and His SmarterCompliance FDA Advisory Program in GxP Lifeline
Independent FDA compliance expert, John Avellanet, was recently interviewed on how companies can save money by taking advantage of where the FDA is headed on 21 CFR Part 11 and computer virtualization. - March 20, 2009 - Cerulean Associates LLC
AnaSpec Offers Calcein AM for Live Cell Staining
AnaSpec is pleased to offer Calcein, AM, a cell-permeant and non-fluorescent compound that is widely used for determining cell viability. Non-fluorescent Calcein, AM in live cells is hydrolyzed by intracellular esterases into the strongly green fluorescent anion calcein, and is retained in the... - March 18, 2009 - AnaSpec, EGT Group
MoBiTec GmbH Closes Distribution Agreement for Lactococcus lactis Gene Expression System with NIZO Food Research
NIZO food research has developed a Gram positive gene expression system making use of Lactococcus lactis and its regulation mechanism for the production of the antibiotic peptide nisin, the NIsin Controlled gene Expression system (NICE). The NICE system is already used as a dedicated expression system by many labs all around the world. With NICE, MoBiTec expands its rich portfolio of non-E. coli based expression systems. - March 15, 2009 - MoBiTec GmbH
AnaSpec Launches New Anti-Keratin 10, 13 and 14 Antibodies
AnaSpec has announced type I acidic keratin antibodies (keratin –10, -13 and -14) have been tested in applications such as western blots or IHC. - March 15, 2009 - AnaSpec, EGT Group
AnaSpec Launches New SensoLyte® Rh110 Long Wavelength Plasmin Activity Assay Kit
AnaSpec is pleased to announce the release of another long wavelength protease assay – the SensoLyte® Rh110 Plasmin Activity Assay Kit (Ex/Em=496 nm/520 nm). - March 14, 2009 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with BioPike, LLC
AnaSpec, Inc. and BioPike, LLC today announced a non-exclusive distributor agreement that will allow BioPike, LLC to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased to... - March 13, 2009 - AnaSpec, EGT Group
Sleep Machine Provides Magnetic Solution for Poor Quality Sleep
The Sleep on Command™ Sleep Machine offers consumers a natural way to fall asleep faster, stay asleep longer and wake up feeling more rejuvenated than ever before. The Sleep on Command™ Sleep Machine uses technology based upon natural Earth generated frequencies. These naturally occurring frequencies correlate perfectly with the mind’s stress free brain-wave spectrum. The lowest end of that spectrum correlates perfectly with deep Delta-rhythm sleep. - March 12, 2009 - EarthPulse Tech, LLC
Baxa Corporation Launches “Culture of Safety” Campaign to Recognize National Patient Safety Awareness Week
New Baxa Corporation campaign targets push towards cultural changes that promote patient safety. The campaign is timed to launch during National Patient Safety Awareness Week, March 8-14, targeting both pharmacy and nursing staff in U.S. hospitals. - March 12, 2009 - Baxa Corporation
IonSense Announces the Greening of DART® Ion Source Technology
iPod Enabled Controller Facilitates Analysis with Nitrogen Gas, Simplifying Operation and Reducing Generation of Waste Products. - March 08, 2009 - IonSense, Inc.
MDS Nordion to Host Physician Expert Teams from Banner Good Samaritan Medical Center and UNC School of Medicine at SIR 2009
MDS Nordion event information for the Society of Interventional Radiology 2009 Scientific Meeting. - March 07, 2009 - MDS Nordion
MDS Nordion to Demonstrate Improved TheraSphere® Administration System During SIR 2009
MDS Nordion event information for the Society of Interventional Radiology 2009 Scientific Meeting. - March 07, 2009 - MDS Nordion
Quintiles Named to Training Top 125 for Workforce Training and Development Excellence
Quintiles Transnational Corp., the world’s largest pharmaceutical services company, has been named to TRAINING magazine’s “Training Top 125,” the publication’s annual report that ranks companies based on their employer-sponsored training and development... - March 06, 2009 - Quintiles
Quantimetrix Corporation Releases New Package Design
Quantimetrix Corporation announces its newly redesigned product packaging. - March 05, 2009 - Quantimetrix Corporation
Genescient and Kronos Announce Alzheimer's Disease Collaboration
Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer's Case-Control Database, considered to be the finest Alzheimer's Disease genetic data set in the US. The companies hope to identify genes previously unrecognized genes that are involved in Alzheimer's Disease. - March 04, 2009 - Genescient Corporation
Baxa Corporation Acquires Florida-Based ForHealth Technologies™
Baxa Corporation, a leading developer of technology for the safe handling, packaging and administration of fluid medications, today announced that it has acquired ForHealth Technologies, Inc., a Florida-based healthcare robotics and software company. The ForHealth acquisition adds IntelliFill i.v.® and IntelliFlowRx™ to the existing Baxa products for pharmacy operations management. - March 03, 2009 - Baxa Corporation
New Hope in Cancer Treatment for Dogs: PharmaCom BioVet’s Veterinary Oncology Treatment Centers
“We lost three of our Siberian Huskies …close family members, to cancer.” The Bertholds vowed, “We would spend the rest of our lives for the sake of our living dogs — in addition to all other dogs — attempting to find better, improved cancer treatments.” PharmaCom BioVet is truly “a union of compassion and technology.” - March 03, 2009 - PharmaCom BioVet
FDA Regulatory Agenda for 2009 Matches Forecast by Cerulean Associates LLC
The FDA's CDER released its 2009 agenda last week, most of which mirrored many of the 40+ recommendations published by Cerulean Associates in its December 2008 SmarterCompliance newsletter. - March 02, 2009 - Cerulean Associates LLC
AnaSpec Introduces Newest GO™ Peptides - Exendins
Along with a host of popular Exendin peptides, AnaSpec’s GO™ Peptides line includes Fluorescein-Trp25-Exendin-4 (FLEX) and [Cys(HiLyteFluor 647 C2 maleimide)]-Exendin-4 - two exendin peptides that are not immediately available anywhere else. - March 01, 2009 - AnaSpec, EGT Group
Techno-Derm Debuts Clayton Shagal’s Collagen - The First 99% Pure, Professional-Grade Collagen Formulation with 100% Efficacy
Techno-Derm announced today that it’s distributing Clayton Shagal’s Collagen, the first 99% pure, professional-grade collagen formulation on the market able to penetrate protective skin barriers and restore collagen fibrils with 100% efficacy. Comprising about 90% of connective tissue,... - February 27, 2009 - Techno-Derm, LLC
Announcing the Launch of the New 25-OH Vitamin D ELISA: Exceptional Correlation to LC-MS/MS in a User-Friendly, Automatable ELISA Format
Serum measurements of 25-OH vitamin D by ELISA are easy and cost-effective for research laboratories who do not have access to the gold standard method, LC-MS/MS with the new 25-OH vitamin D ELISA kit offered by ALPCO. - February 27, 2009 - ALPCO
AnaSpec Introduces Cost-Effective Replacement for Tetramethyl Rhodamine Maleimides
AnaSpec has introduced a collection of Tetramethylrhodamine C2 maleimides that represent an equally effective and more cost-effective replacement for Tetramethyl rhodamine maleimides. - February 27, 2009 - AnaSpec, EGT Group
Trevigen Releases CultreCoat® Cell Adhesion Assays
Trevigen announces the immediate availability of seven new coated well assay kits for cell adhesion studies. - February 25, 2009 - Trevigen, Inc.
Two FDA Quality Systems Compliance Resources Published
Two new FDA quality systems compliance resources – "Bulletproof Yourself against FDA Enforcement" and "FDA Quality Systems Records Requirements for GLPs, GCPs, GMPs" – have been published by the SmarterCompliance™ newsletter and Cerulean Associates LLC. - February 22, 2009 - Cerulean Associates LLC
AnaSpec Introduces Industry’s First NMHC II Antibodies
AnaSpec has announced the release of the industry’s first provider of nonmuscle myosin class II heavy chain (NMHC) antibodies. Nonmuscle myosin class II proteins belong to the superfamily of actin-based motor proteins. They form hexamer structures composed of two ~200kDa heavy chains (NMHC... - February 22, 2009 - AnaSpec, EGT Group
Medi Introduces Mediven® Sheer & Soft: Stylish and Comfortable Compression Therapy Treatments Now Available
Medi USA, a worldwide leader in medical therapy products, introduces Mediven® Sheer & Soft, a complete line of fashionable, discreet and comfortable compression therapy stockings suitable for day and evening wear. Independently proven to be more sheer and comfortable than leading competitors, Sheer & Soft stockings are available in a variety of colors. - February 20, 2009 - Medi USA
AnaSpec Introduces Industry’s Most Sensitive Luminescent Alkaline Phosphatase Assay Kits
AnaSpec announced the release of the industry’s most sensitive assay kits for the detection of alkaline phosphatase activities. The SensoLyteTM Luminescent Alkaline Phosphatase and SensoLyteTM Luminescent Alkaline Phosphatase ELISA assay kits contain a chemiluminescent substrate capable of... - February 19, 2009 - AnaSpec, EGT Group
Grand Opening of Masy Systems’ Biorepository
State of the Art Biorepository Opening in February 2009. - February 18, 2009 - Masy Systems
Colorado BioScience Association and Four Area Economic Development Groups Tout Colorado’s Strengths to the Medical Device Industry at MD&M West in Anaheim
For three days, representatives from the Colorado BioScience Association -- along with four of the state’s economic development entities -- will be showcasing Colorado’s vast medical device sector at the 25th annual Medical Design & Manufacturing (MD&M) West Expo. The... - February 12, 2009 - Colorado BioScience Association
Anavex Appoints Leading Alzheimer's Disease Expert Dr. Mark Smith to Scientific Advisory Board
Anavex Life Sciences Corp. today announced the appointment of Dr. Mark A. Smith, Ph.D., FRCPath, to its scientific advisory board. - February 12, 2009 - Anavex Life Sciences Corp.
Pediatric Brain Tumor Foundation Boosts Research Funding by $8 Million
The Pediatric Brain Tumor Foundation (PBTF) increased its medical research funding commitments by $8.35 million in 2008. The grants consist of an additional $6 million to the PBTF Institute at Duke University; $1 million to the PBTF Institute at the University of California San Francisco and $1... - February 08, 2009 - Pediatric Brain Tumor Foundation
Clinical Trials in Russia. Year 2008.
On February 04, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Year 2008, a regular analytical report on the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering... - February 07, 2009 - Synergy Research Group
Baxa Corporation Ranks Seventh in ColoradoBiz Magazine’s Top 50 Family-Owned Companies
Englewood-based Baxa Corporation ranks in the top ten among family-owned businesses in the 8th annual ColoradoBiz magazine listing. Baxa is owned and managed by the sons of founder Brian Baldwin. This is the company’s fifth year on the annual ColoradoBiz magazine list. - February 07, 2009 - Baxa Corporation
Memorial Sloan-Kettering Cancer Center Implements New Lab Disinfection System
Genetic researchers have a greener way to keep their labs free from organic contamination. A new technology uses Ultraviolet light to replace manual cleaning. The UV sterilization technology is safe, effective and greener for the environment. - February 05, 2009 - VIGILAIR Systems Inc.
Anavex Scales Up Synthesis of Anavex 2-73 for Phase 1 Alzheimer’s Disease Study
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) has signed an agreement with organic chemistry services provider Syntagon AB (“Syntagon”) for the scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. ANAVEX 2-73 is... - February 04, 2009 - Anavex Life Sciences Corp.
GeneFluidics Inc. Proteus Robotic System Receives ALA New Product Award
GeneFluidics, Inc. is pleased to announce that their Proteus Robotic System has received the New Product Award from the Association for Laboratory Automation (ALA) at LabAutomation2009. The ALA is an international organization devoted to the study, development, and use of laboratory automation. - February 03, 2009 - GeneFluidics Inc.